GlassScriptPhysician profile
Jonathan I Telsey
NPI 1992868434
$526.22
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $157 · 2020: $15.97 · 2021: $21.14 · 2022: $76.54 · 2023: $160 · 2024: $96.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $255.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $64.30 | 2019-2023 | |
| Blue Earth Diagnostics | $42.09 | 2019-2020 | |
| Pfizer INC. | $41.71 | 2023-2024 | |
| Urovant Sciences INC | $40.33 | 2021-2022 | |
| Astellas Pharma US INC | $39.82 | 2022 | |
| Karl Storz Endoscopy-America | $34.90 | 2019 | |
| Allergan, INC. | $34.62 | 2019 | |
| Procept Biorobotics Corporation | $32.63 | 2024 | Aquabeam System |
| Hollister Incorporated | $26.77 | 2023 | Vapro Plus Pocket |
| Covidien LP | $24.48 | 2019 | |
| Sumitomo Pharma America, INC. | $23.53 | 2024 | Orgovyx |
| C. R. Bard, INC. & Subsidiaries | $23.23 | 2024 | Bard Urinary Drainage Bag |
| Urogen Pharma, INC. | $23.11 | 2023 | Jelmyto |
| Baxter Healthcare | $22.04 | 2019 | |
| Alnylam Pharmaceuticals INC. | $19.87 | 2023 | Givlaari |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $17.53 | 2022 | |
| Laborie Medical Technologies Corp. | $15.26 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Telsey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.